BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 2696217)

  • 1. [Therapeutic consequences of hemorheologic research].
    Ernst E
    Wien Med Wochenschr; 1989 Dec; 139(24):569-80. PubMed ID: 2696217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Therapy from the hemorheologic viewpoint. 1: Hemodilution and defibrinogenation].
    Ernst E
    Fortschr Med; 1986 Jun; 104(21):423-6. PubMed ID: 3732982
    [No Abstract]   [Full Text] [Related]  

  • 3. [Blood rheology in peripheral occlusive disease. Effects of hemodilution and pentoxifylline].
    Angelkort B
    Wien Med Wochenschr; 1986; 136 Spec No():29-35. PubMed ID: 3548089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Treatment of peripheral arterial occlusive disorders with rheologically active measures].
    Turowski A; Schmidt HH; Sternitzky R
    Z Arztl Fortbild (Jena); 1987; 81(17):883-8. PubMed ID: 3439205
    [No Abstract]   [Full Text] [Related]  

  • 5. [Anti-thixotropic therapy in arterial occlusive disorders: What is the effectiveness of "rheological procedures" in the presence of persisting obliterations?].
    Schmid-Schönbein H
    Wien Med Wochenschr; 1985 Aug; 135(15-16):368-79. PubMed ID: 4060740
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hemorheologic, micro- and macrocirculatory effects of an infusion of 500 ml of 6% medium molecular weight hydroxyethyl starch (Haes 200,000/0.5)].
    Jung F; Waldhausen P; Mrowietz C; Spitzer S; Kiesewetter H; Wenzel E
    Infusionstherapie; 1989 Aug; 16(4):148-54. PubMed ID: 2478482
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hemorheologic therapy in peripheral arterial occlusive disease].
    Kiesewetter H; Jung F
    Fortschr Med; 1984 Oct; 102(37):921-4. PubMed ID: 6500451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of hemorheology in the pathophysiology and treatment of arterial occlusive disease.
    Rieger H
    Int Angiol; 1986; 5(3):161-7. PubMed ID: 3559317
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Heparin-induced extracorporeal LDL precipitation (HELP): a new therapeutic intervention in cerebrovascular diseases and peripheral arterial occlusive disease].
    Walzl B; Walzl M; Lechner P; Lechner H; Cesnik H
    Wien Med Wochenschr; 1993; 143(22):563-70. PubMed ID: 8154130
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Hemorheologic therapy applications in coronary heart disease].
    Leschke M; Motz W; Strauer BE
    Wien Med Wochenschr; 1986; 136 Spec No():17-24. PubMed ID: 3825169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Experiences with the clinical use of iso- and hypervolemic hemodilution in conservative therapy of vascular diseases].
    Turowski A; Schmidt H; Sternitzky R; Brehme S; Keysser G; Hiebsch G; Hiebsch U
    Vasa Suppl; 1991; 32():338-41. PubMed ID: 1771528
    [No Abstract]   [Full Text] [Related]  

  • 12. [Induced hemodilution as a new concept in the therapy of peripheral circulatory disorders].
    Rieger H
    Internist (Berl); 1982 Jul; 23(7):375-82. PubMed ID: 7049999
    [No Abstract]   [Full Text] [Related]  

  • 13. [Whole blood viscosity in patients with acral arterial occlusive diseases and their modification by rheologically active drugs].
    Runge E; Thiele P
    Z Gesamte Inn Med; 1987 Mar; 42(5):137-41. PubMed ID: 3590891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The pharmacological approach in hemorheology].
    Sarno A; Caimi G
    Ric Clin Lab; 1985; 15 Suppl 1():479-97. PubMed ID: 3898325
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hemodilution].
    Landgraf H
    Wien Med Wochenschr; 1986; 136 Spec No():36-40. PubMed ID: 3548090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hemorheologic and clinical in vitro and in vivo studies of the effectiveness of isovolemic hemodilution using Gelafusal and Infukoll M40 in patients with peripheral arterial occlusive disease].
    Pöhlmann G; Braumann A; Grohmann G
    Vasa Suppl; 1991; 32():342-4. PubMed ID: 1722914
    [No Abstract]   [Full Text] [Related]  

  • 17. [Therapy with hemorheologic considerations. 2: Rheologic agents].
    Ernst E
    Fortschr Med; 1987 Feb; 105(4):69-72. PubMed ID: 3557263
    [No Abstract]   [Full Text] [Related]  

  • 18. [Results of the Berlin HOT/UVB comparative study in patients with peripheral arterial occlusive disorders].
    Paulitschke M; Turowski A; Lerche D
    Z Gesamte Inn Med; 1992 Apr; 47(4):148-53. PubMed ID: 1595300
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Blood rheological changes and their clinical significance in chronic arterial obstructive disease].
    Sternitzky R; Seige K
    Z Gesamte Inn Med; 1983 Jan; 38(1):1-7. PubMed ID: 6342278
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The influence of hemorrheology on the practice of clinical medicine].
    Dormandy JA
    Ric Clin Lab; 1983; 13 Suppl 3():7-27. PubMed ID: 6369497
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.